Mr. Pizza, whose wife was serenaded by Trump at Mar-a-Lago, is a hydroxychloroquine dealer.
prescription drugs
Behind the Coronavirus Threat, a Middleman Destroying Prescription Drug Markets
Group purchasing organizations (GPOs) have driven many of the generic drug manufacturers out of business, and pushed those remaining to locate factories in China, ground zero for the epidemic.
Pharma-Funded ‘Dark Money’ Group Hosts House Staffers for California Junket
The staffers, several of whom work for reps on the subcommittee overseeing pharmaceuticals, met with executives from drug companies Merck and Genentech.
Under Cover of Impeachment, Pelosi Wraps Up a Year’s Policymaking in 24 Hours
While nobody was looking, the House Speaker resolved major end-of-the-year policy deals. Here’s the good, the bad, and the ugly.
Bernie Sanders, Elizabeth Warren Team Up With House Progressives to Challenge Nancy Pelosi on Drug Bill
The Progressive Caucus is threatening to vote down a drug pricing bill important to Nancy Pelosi. Bernie Sanders and Elizabeth Warren have backed them up.
Mother of Insulin Victim on Pelosi’s Drug Price Bill: ‘It Wouldn’t Have Saved My Son’s Life’
The Lower Drug Costs Now Act, with its critical gaps and questionable strategy, is a microcosm of how House Democratic leaders have done policy all year.
Warren’s Medicare for All Plan Includes No New Taxes on the Middle Class
The deeply detailed proposal cuts health care costs and finds other revenues, saving ordinary Americans $11 trillion in premiums and deductibles.
When Pharma Needs a Friend: Conservative House Democrats Move to Protect Drug Company Profits
A letter from 11 Democrats expresses support for a drug patent provision in the NAFTA update that most of their caucus opposes.
Pramila Jayapal Takes On Medicare for All’s Critics
The Progressive Caucus co-chair authored the House Medicare for All bill. She’s frustrated that Democrats are attacking the concept of universal health care for political advantage.
FTC About to Let Through a ‘Killer Acquisition’
In this Capitol Forum report, the merger of Roche and Spark Therapeutics, which could squash a cure for hemophilia while allowing Roche’s medication for it to thrive, is poised to be approved.

